...NASDAQ:XOMA) received for autoimmune drug Cimzia certolizumab pegol; and undisclosed rights from transfusion products company Velico Medical Inc....

...2010, OrbiMed acquired royalty rights from private transfusion products company Velico Medical Inc. for an undisclosed sum. Velico...

...1, 2009 Patent pending covering compositions and methods for prolonging survival of platelets; licensed to Velico Medical Inc....